Radicaloid TTFtt Bimetallic Complexes for Bright NIR-II Imaging
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current NIR dyes face challenges such as low photoluminescence quantum yields (PLQY), autofluorescence, scattering, and water absorption, which limit their effectiveness in biological imaging and therapeutic applications, particularly in the NIR II region.
Innovation Solution
Development of dicationic tetrathiafulvalene-2,3,6,7-tetrathiolate bridged bimetallic compounds with diradical character that exhibit bright, air- and water-stable near-infrared emission, enabling redox-switchable and tunable luminescence for imaging and therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Illumination intensity
If molecular organic NIR dyes are designed to emit in the NIR II region (≥1200 nm), then the emission wavelength is improved, but the photoluminescence quantum yield deteriorates to extremely low values (≤ 0.05%)
Solution Approach 1:
The patent changes the fundamental parameters of the emitting system by transitioning from molecular organic dyes to inorganic semiconductor quantum dots. This parameter change enables simultaneous achievement of NIR II emission wavelength (≥1200 nm) and high photoluminescence quantum yield (>50%), resolving the contradiction between emission wavelength and energy loss.
2Illumination intensity
If the molecular size is increased to red-shift emission into the NIR region, then the emission wavelength is improved, but the synthetic complexity and solubility deteriorate
Solution Approach 1:
The patent segments the complex molecular system into simpler inorganic quantum dot cores with separate surface functionalization layers. This segmentation allows independent optimization of optical properties (emission wavelength) and chemical properties (solubility, synthetic complexity), resolving the contradiction between emission wavelength and molecular complexity.
Solution Approach 2:
The patent employs composite material structures where inorganic semiconductor cores are combined with organic surface ligands and shell layers. This composite approach enables tuning of emission wavelength through core size while maintaining solubility and reducing synthetic complexity through modular surface functionalization.
3Adaptability or versatility
If water solubility is increased for biological applications, then the biocompatibility is improved, but the photoluminescence quantum yield deteriorates dramatically
Solution Approach 1:
The patent separates the functions of water solubility and photoluminescence by placing hydrophilic surface ligands on the quantum dot surface while maintaining the photoluminescent inorganic core. This segmentation allows independent optimization, achieving both high water solubility and high photoluminescence quantum yield (>50%), resolving the contradiction between adaptability and energy loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds provide high PLQY, photostability, and redox-switchability, making them suitable for various applications including NIR sensing, quantum sensing, and therapeutic interventions with improved imaging capabilities.
Implementation Method 1
Molecular near-infrared (NIR) dyes and lumiphores have attracted attention due to their promising applications in biological imaging
Implementation Method 2
TTFs can act as molecular redox switches, as they are reversibly oxidizable to dications or stable radical cations without decomposition or side reactions
Data Source
AI summary
Tetrathiafulvalene-2,3,6,7-tetrathiolate (TTFtt) bridged bimetallic complexes with radical character which are bright, air- and water-stable, persistent and exhibit excellent near-infrared photophysical properties; and methods of use of the TTFtt complexes for imaging, guidance of surgery, as qubits, and for interventional medical treatments as theranostic agents are described.